Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRONCHILD Feasibility Trial
NCT04371536Phase 3Completed
- Sponsor
- Baylor College of Medicine
- Start
- Jul 2021
- Primary completion
- Feb 2022
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Baylor College of Medicine. Primary endpoints: Percentage of Eligible Patients Enrolled and Percentage of Enrolled Subjects Who Agree With Randomization. Started Jul 2021; status: completed.
Beyond the preview
Go deeper on NCT04371536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04371536.